Apr 25, 2018 by Brian Feroldi, Sean Williams, and Maxx Chatsko3 Stocks That Feel Like Netflix in 2002These three companies look poised for takeoff.
Apr 24, 2018 by Brian FeroldiThree Small-Cap Tech Companies for Your Watch ListThese three small-caps are scrappy, sticky, and have a lot of room to grow -- and some incredibly solid business models that can help them do that.
Apr 24, 2018 by Brian FeroldiCustomer Woes Cause Healthcare Services Group's First-Quarter Profits to EvaporateA $35 million charge related to two customer restructurings causes the company's profits to fall drastically.
Apr 23, 2018 by Brian FeroldiWhy Prothena Corporation plc Is Imploding TodayShares plunge after the company announces that it is halting development of its lead pipeline candidate. Here's what investors need to know.
Apr 15, 2018 by Brian Feroldi, Demitri Kalogeropoulos, and Leo Sun3 Dividend Stocks That Pay You More Than Verizon DoesLooking for income? Check out these dividend dynamos.
Apr 13, 2018 by Brian FeroldiWhy Glaukos Corp. Is Sinking TodayShares tumble after a Wall Street analyst cuts his rating. Here's what investors need to know.
Apr 13, 2018 by Brian Feroldi, Sean Williams, and Maxx Chatsko3 Top Index Funds to Keep You in the Investing GameDo you prefer to take a hands-off approach to investing? These three index funds could be for you.
Apr 12, 2018 by Brian FeroldiHere's Why Novavax, Inc. Is SinkingShares plunged after the clinical-stage vaccine maker gave details on the pricing of its recently announced common stock offering.
Apr 10, 2018 by Brian FeroldiWhy Spectrum Pharmaceuticals, Inc. Is Soaring TodayTraders cheer after the company shares additional data from an important phase 2 trial.
Apr 9, 2018 by Brian FeroldiWhy Acadia Pharmaceuticals Is Crashing TodayTraders flee after a troublesome news report emerged related to the company's only drug, Nuplazid. Here's what investors need to know.
Apr 8, 2018 by Brian FeroldiIs Exact Sciences Corp. Still a Buy in 2018?Shareholders in the innovative colon cancer test specialist have enjoyed huge gains over the last few years.
Apr 7, 2018 by Brian FeroldiBetter Buy: Eli Lilly and Co. vs. GlaxoSmithKlineBoth of these pharmaceutical giants are trading at cheap valuations and offer big dividends, due to troubles that are mostly behind them.
Apr 6, 2018 by Brian FeroldiWhy Codexis, Inc. Stock Is Tumbling TodayShares plunged after the company announced the pricing details of a common stock offering.
Apr 6, 2018 by Brian Feroldi, Sean Williams, and Maxx Chatsko3 High-Growth Stocks That Could SoarLooking for stocks with explosive growth potential? Check these out.
Apr 6, 2018 by Brian Feroldi, Demitri Kalogeropoulos, and Leo Sun3 Stocks to Buy and Hold for DecadesLooking for a few set-it-and-forget-it investments? Give these three companies a look.
Apr 4, 2018 by Brian FeroldiHere's Why Senseonics Holdings Inc. Is Rising TodayShares jump after the company receives some favorable commentary from a Wall Street analyst.
Apr 4, 2018 by Brian Feroldi, Demitri Kalogeropoulos, and Leo Sun3 Growth Stocks at Deep-Value PricesLooking for stocks that promise growth and are trading on the cheap? Give these three beaten-up businesses a closer look.
Apr 3, 2018 by Brian FeroldiBetter Buy: Acadia Pharmaceuticals vs. Eli LillyThese two pharma companies are in very different stages of their life cycle, but which is more deserving of capital today?
Apr 2, 2018 by Brian FeroldiHere's Why Alkermes plc and Intra-Cellular Therapies, Inc. Are Crashing TodayBummer regulatory news causes traders to flee from these two biopharmas. Here's what investors need to know.
